A group of creditors filed an involuntary petition for reorganization under Chapter 11 against Statera Biopharma, Inc. in the US Bankruptcy Court for the District of Colorado on August 16, 2022. The total claim amount of the petitioning creditors was $2.09 million. The petitioning creditors are represented by Craig M. Geno of Law Offices of Craig M. Geno, PLLC and Timothy Swanson of Moye White LLP as their legal counsels.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0006 USD | -.--% | -14.29% | -.--% |
2023 | Statera Biopharma, Inc. entered into a letter of intent to acquire Worksite Labs. | CI |
2023 | Statera Biopharma, Inc.(OTCPK:STAB) dropped from S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 43.55K | |
+49.67% | 54.63B | |
-4.82% | 39.92B | |
+37.09% | 38.82B | |
+16.05% | 26.86B | |
-12.56% | 26.22B | |
-21.62% | 18.78B | |
+25.78% | 12.21B | |
+1.94% | 12.16B | |
+26.93% | 11.94B |
- Stock Market
- Equities
- STAB Stock
- News Statera Biopharma, Inc.
- Involuntary Petition Filed Against Statera Biopharma, Inc.